Dioscin showed potent effects against BDL- and DMN-induced liver fibrosis in rats.
Dioscin significantly suppressed oxidative stress.
Dioscin triggered Sirt1/Nrf2-mediated inhibition of p38 MAPK pathway.
Dioscin should be developed as a novel candidate to treat liver fibrosis.